Skip to content
Recall Observatory FDA recall evidence

Device product

AFX Endovascular AAA System, Endoleak Type IIIA Product Usage: The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (AAA).

Z-1047-2017

December 27, 2016

Class II

Product summary

Firm
Endologix
Event
Event 76112
Status
Terminated
Classification
Class II
Quantity
Unavailable
Official record key
device-enforcement:Z-1047-2017

Official wording

Reason: Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).

Code information: The correction is not lot specific. It applies to AFX procedures conducted after October 2015

Distribution pattern: US and worldwide: Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Israel, Italy, Latvia, Luxembourg, Monaco, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, Turkey, United Kingdom.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).